Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
Adachi K, Xu J, Ank B, Watts DH, Mofenson LM, Pilotto JH, Joao E, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Gray G, Theron G, Morgado MG, Bryson YJ, Veloso VG, Klausner JD, Moye J, Nielsen-Saines K; NICHD HPTN 040 Study Team. Adachi K, et al. Among authors: moye j. Clin Infect Dis. 2017 Aug 1;65(3):405-413. doi: 10.1093/cid/cix222. Clin Infect Dis. 2017. PMID: 28369278 Free PMC article. Clinical Trial.
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Moye J Jr, Bethel J, Hirschhorn R, Jordan C, Nugent R. Mofenson LM, et al. Among authors: moye j jr. JAMA. 1992 Jul 22-29;268(4):483-8. doi: 10.1001/jama.268.4.483. JAMA. 1992. PMID: 1352363 Clinical Trial.
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Moye J Jr, Korelitz J, Bethel J, Hirschhorn R, Nugent R. Mofenson LM, et al. Among authors: moye j jr. Pediatr Infect Dis J. 1994 Jun;13(6):477-84. doi: 10.1097/00006454-199406000-00003. Pediatr Infect Dis J. 1994. PMID: 8078734 Clinical Trial.
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Bethel J, Moye J Jr, Flyer P, Nugent R. Mofenson LM, et al. Among authors: moye j jr. J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1103-13. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8105072 Clinical Trial.
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Korelitz J, Pelton S, Moye J Jr, Nugent R, Bethel J. Mofenson LM, et al. Among authors: moye j jr. Clin Infect Dis. 1995 Nov;21(5):1175-81. doi: 10.1093/clinids/21.5.1175. Clin Infect Dis. 1995. PMID: 8589139 Clinical Trial.
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
Mofenson LM, Korelitz J, Meyer WA 3rd, Bethel J, Rich K, Pahwa S, Moye J Jr, Nugent R, Read J. Mofenson LM, et al. Among authors: moye j jr. J Infect Dis. 1997 May;175(5):1029-38. doi: 10.1086/516441. J Infect Dis. 1997. PMID: 9129063 Clinical Trial.
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group.
Lambert JS, Mofenson LM, Fletcher CV, Moye J Jr, Stiehm ER, Meyer WA 3rd, Nemo GJ, Mathieson BJ, Hirsch G, Sapan CV, Cummins LM, Jimenez E, O'Neill E, Kovacs A, Stek A. Lambert JS, et al. Among authors: moye j jr. J Infect Dis. 1997 Feb;175(2):283-91. doi: 10.1093/infdis/175.2.283. J Infect Dis. 1997. PMID: 9203648 Clinical Trial.
309 results